Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS)
MACS/WIHS 联合队列研究 (MACS/WIHS-CCS) 的临床研究中心
基本信息
- 批准号:10612796
- 负责人:
- 金额:$ 409.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcquired Immunodeficiency SyndromeAgeAgingAreaBaltimoreBone DiseasesCaliberCardiovascular DiseasesCardiovascular systemCaringCervicalCervical Cancer ScreeningChronicCohort StudiesCollaborationsCollectionCommunitiesDataData AnalysesData Coordinating CenterDevelopmentDiseaseDisease ProgressionDrug KineticsEchocardiographyEducationEnrollmentEnsureEpidemicEventFarGoFemale genitaliaFosteringFractureFundingGeneticGuidelinesHIVHIV InfectionsHealthHuman PapillomavirusHuman papilloma virus infectionImmunologic FactorsInflammationInstitutionInvestigationInvestigator-Initiated ResearchLeadLeadershipLinkLongevityLongterm Follow-upMalignant NeoplasmsMeasuresMentorshipMetabolicMetabolic DiseasesMetabolismMethodsMethylationMinority MenMonitorMorbidity - disease rateMucosal ImmunityNatural HistoryNeurocognitive DeficitObesityOutcomeParticipantPathogenesisPersonsPlayPopulationPrincipal InvestigatorProcessProductivityProtocols documentationPublicationsReadingRecording of previous eventsResearchResearch InfrastructureResearch PersonnelResourcesRiskRoleScienceSeriesSiteSleep disturbancesSpecimenSystemTechniquesThe Multicenter AIDS Cohort StudyUnited StatesUnited States National Institutes of HealthVisceralVisitWomanWomen&aposs Interagency HIV StudyWorkadjudicationantiretroviral therapycardiovascular imagingcareer developmentcervicovaginal microbiomeclinical research sitecohortcomorbiditydata sharingethnic disparityethnic minorityexperiencefallsfecal microbiomeflexibilityfrailtyfunctional disabilityhealth disparityimmune activationinflammatory markerinnovationmenmetabolomicsmicrobiomemicrobiome componentsmicrobiome researchmortalityoral microbiomeorganizational structurepatient retentionpremalignantracial disparityracial minorityrecruitreproductive tractresearch studyretention ratesex disparitysuccesstranslational studytreatment responsevaginal microbiomevaginal mucosa
项目摘要
Principal Investigator: Anastos, Kathryn/Sharma Anjali
PROJECT SUMMARY/ABSTRACT
With increasingly effective universal antiretroviral therapy (ART), people living with HIV (PLWH) may now
live nearly normal lifespans. With that success however, comes a series of chronic HIV-related comorbidities,
whose mechanisms are poorly understood, but thought to be related to inflammation and immune activation.
As PLWH age, they are experiencing this high burden of non-AIDS comorbidities at younger than expected age,
including cardiovascular and metabolic diseases, cancers, and neurocognitive and functional impairment -
leading some to suggest that HIV may both accentuate AND accelerate aging. The Women's Interagency HIV
Study (WIHS) and the Multicenter AIDS Cohort Study (MACS) cohorts, with long-term follow up over 25 and
35 years provide the ability to measure the onset, progression and impact of HIV-related comorbid disease and
provide a platform for critically important translational studies of pathogenesis in cardiovascular disease
(CVD), human papillomavirus (HPV), aging, and HIV-disease progression. As these two highly successful and
critically important cohorts merge, the Bronx Clinical Research Site (CRS) will support the new Combined
Cohort Study (CCS) in an effort to understand and advance the study of HIV infection and its treatment, with a
focus on HIV-related comorbidities and aging with HIV. The Bronx CRS will provide scientific leadership to
the CCS in three specific areas: CVD, microbiome studies, and HPV infection and disease. In particular, the
Bronx CRS will provide innovative scientific leadership in studying CVD among PLWH with a longitudinal
echocardiography study and a high-caliber Echo Reading Center, including cutting-edge cardiovascular
imaging, and the study of CVD in relation to inflammatory markers, metabolomics, and microbiome among
PLWH. The Bronx CRS will continue to follow our large numbers of well-characterized persons living with and
without HIV, as well as recruit primarily racial and ethnic minority men and women with or at-risk for HIV to
reflect our local NYC HIV epidemic, thus allowing us to investigate the impact of age, sex, race/ethnicity, and
health disparities on HIV disease progression and its relation to comorbid illnesses across the lifespan. The
value of these studies goes far beyond the United States, to inform the global HIV epidemic, and care of PLWH.
主要研究者:Anabel,Kathryn/Sharma Anjali
项目总结/摘要
随着普遍抗逆转录病毒疗法(ART)越来越有效,艾滋病毒感染者(PLWH)现在可能
都过着正常的生活然而,随着这一成功,出现了一系列与艾滋病毒相关的慢性合并症,
其机制知之甚少,但被认为与炎症和免疫激活有关。
随着PLWH年龄的增长,他们在比预期年龄更小的时候就经历了非艾滋病合并症的高负担,
包括心血管和代谢疾病、癌症、神经认知和功能障碍-
导致一些人认为艾滋病毒可能会加重和加速衰老。妇女机构间艾滋病毒
研究(WIHS)和多中心艾滋病队列研究(MACS)队列,长期随访超过25岁,
35年提供了衡量艾滋病毒相关共病的发病、进展和影响的能力,
为心血管疾病发病机制的重要转化研究提供平台
(CVD)、人乳头瘤病毒(HPV)、衰老和HIV疾病进展。这两个非常成功的,
对于非常重要的队列合并,布朗克斯临床研究中心(CRS)将支持新的合并
队列研究(CCS)旨在了解和推进艾滋病毒感染及其治疗的研究,
重点关注与艾滋病毒相关的合并症和艾滋病毒感染的老龄化。布朗克斯CRS将提供科学的领导,
CCS在三个特定领域:CVD,微生物组研究,HPV感染和疾病。特别是
布朗克斯CRS将提供创新的科学领导,在PLWH中研究CVD,
超声心动图研究和高素质的回声阅读中心,包括尖端的心血管
影像学,以及CVD与炎症标志物,代谢组学和微生物组学的研究,
PLWH。布朗克斯CRS将继续跟踪我们大量的性格特征良好的人,
没有艾滋病毒,以及招募主要是种族和少数民族的男子和妇女与艾滋病毒或艾滋病毒的风险,
反映我们当地的纽约市艾滋病毒流行,从而使我们能够调查年龄,性别,种族/民族的影响,
艾滋病毒疾病进展的健康差异及其与整个生命周期共病的关系。的
这些研究的价值远远超出了美国,为全球艾滋病毒流行和艾滋病感染者的护理提供信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kathryn M. Anastos其他文献
Kathryn M. Anastos的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kathryn M. Anastos', 18)}}的其他基金
Rwanda CASCADE Clinical Trials Site for cervical cancer prevention
卢旺达 CASCADE 宫颈癌预防临床试验基地
- 批准号:
10757692 - 财政年份:2023
- 资助金额:
$ 409.36万 - 项目类别:
Einstein/Rwanda DRC Consortium for Research in HIV/HPV Malignancies
爱因斯坦/卢旺达刚果民主共和国 HIV/HPV 恶性肿瘤研究联盟
- 批准号:
10414093 - 财政年份:2020
- 资助金额:
$ 409.36万 - 项目类别:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/ Malignancies
爱因斯坦/卢旺达/刚果民主共和国艾滋病毒/HPV/恶性肿瘤研究联盟
- 批准号:
10267220 - 财政年份:2020
- 资助金额:
$ 409.36万 - 项目类别:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV Malignancies
爱因斯坦/卢旺达/刚果民主共和国 HIV/HPV 恶性肿瘤研究联盟
- 批准号:
10267222 - 财政年份:2020
- 资助金额:
$ 409.36万 - 项目类别:
Einstein/Rwanda DRC Consortium for Research in HIV/HPV Malignancies
爱因斯坦/卢旺达刚果民主共和国 HIV/HPV 恶性肿瘤研究联盟
- 批准号:
10267223 - 财政年份:2020
- 资助金额:
$ 409.36万 - 项目类别:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV Malignancies
爱因斯坦/卢旺达/刚果民主共和国 HIV/HPV 恶性肿瘤研究联盟
- 批准号:
10084653 - 财政年份:2020
- 资助金额:
$ 409.36万 - 项目类别:
Einstein/Rwanda DRC Consortium for Research in HIV/HPV Malignancies
爱因斯坦/卢旺达刚果民主共和国 HIV/HPV 恶性肿瘤研究联盟
- 批准号:
10084655 - 财政年份:2020
- 资助金额:
$ 409.36万 - 项目类别:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/ Malignancies
爱因斯坦/卢旺达/刚果民主共和国艾滋病毒/HPV/恶性肿瘤研究联盟
- 批准号:
10654706 - 财政年份:2020
- 资助金额:
$ 409.36万 - 项目类别:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV Malignancies
爱因斯坦/卢旺达/刚果民主共和国 HIV/HPV 恶性肿瘤研究联盟
- 批准号:
10654712 - 财政年份:2020
- 资助金额:
$ 409.36万 - 项目类别:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/Malignancies
爱因斯坦/卢旺达/刚果民主共和国艾滋病毒/HPV/恶性肿瘤研究联盟
- 批准号:
10654699 - 财政年份:2020
- 资助金额:
$ 409.36万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 409.36万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 409.36万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 409.36万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 409.36万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 409.36万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 409.36万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 409.36万 - 项目类别: